Andrade-Machado R et al (2015) Suicidal risk, affective dysphoric disorders, and quality-of-life perception in patients with focal refractory epilepsy. Epilepsy Behav 45:254–260

Article  PubMed  Google Scholar 

Christian P, Christine N (2005) Mood disorders and their treatment in patients with epilepsy. he. J Neuropsychiatry Clin Neurosci 17:20–28

Article  Google Scholar 

Gulyaeva NV (2021) Stress-associated molecular and cellular hippocampal mechanisms common for epilepsy and comorbid depressive disorders. Biochemistry (Mosc) 86(6):641–656

Article  PubMed  CAS  Google Scholar 

Rafnsson V, Ólafsson E, Hauser WA (2001) Gunnar Gudmundsson, Cause-specific mortality in adults with unprovoked seizures. Neuroepidemiology 20:232–236

Article  PubMed  CAS  Google Scholar 

Fiest KM et al (2014) Patterns and frequency of the treatment of depression in persons with epilepsy. Epilepsy Behav 39:59–64

Article  PubMed  Google Scholar 

Lothe A et al (2008) Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131(Pt 10):2765–2782

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kanner AM (2013) The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia 54(Suppl 1):3–12

Article  PubMed  CAS  Google Scholar 

Grone BP, Baraban SC (2015) Animal models in epilepsy research: legacies and new directions. Nat Neurosci 18(3):339–343

Article  PubMed  CAS  Google Scholar 

Loscher W, Stafstrom CE (2023) Epilepsy and its neurobehavioral comorbidities: insights gained from animal models. Epilepsia 64(1):54–91

Article  PubMed  Google Scholar 

Vezzani A (2014) Epilepsy and inflammation in the brain: overview and pathophysiology. 14:3–7

Maguire J (2022) Mechanisms of psychiatric comorbidities in epilepsy. Curr Top Behav Neurosci 55:107–144

Article  PubMed  Google Scholar 

Wells GA et al. (2021) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

Crail-Melendez D et al (2012) Cognitive-behavioral therapy for depression in patients with temporal lobe epilepsy: a pilot study. Epilepsy Behav 23(1):52–56

Article  PubMed  CAS  Google Scholar 

Macrodimitris S et al (2011) Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety. Epilepsy Behav 20(1):83–88

Article  PubMed  CAS  Google Scholar 

de Barros ACS et al (2018) Effects of a psychotherapeutic group intervention in patients with refractory mesial temporal lobe epilepsy and comorbid psychogenic nonepileptic seizures: a nonrandomized controlled study. Seizure 58:22–28

Article  PubMed  Google Scholar 

Kuhn KU et al (2003) Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4(6):674–679

Article  PubMed  Google Scholar 

Specchio LM et al (2004) Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 27:133–136

Article  PubMed  CAS  Google Scholar 

Gilliam FG et al (2019) A trial of sertraline or cognitive behavior therapy for depression in epilepsy. Ann Neurol 86(4):552–560

Article  PubMed  PubMed Central  Google Scholar 

Orjuela-Rojas JM et al (2015) Treatment of depression in patients with temporal lobe epilepsy: a pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors. Epilepsy Behav 51:176–181

Article  PubMed  Google Scholar 

Thome-Souza MS, Kuczynski E, Valente KD (2007) Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 10(3):417–425

Article  PubMed  CAS  Google Scholar 

Gandy M et al (2014) Cognitive behaviour therapy to improve mood in people with epilepsy: a randomised controlled trial. Cogn Behav Ther 43(2):153–166

Article  PubMed  Google Scholar 

Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: new roles for the synaptic stripper. Neuron 77(1):10–18

Article  PubMed  CAS  Google Scholar 

Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87(5):779–789

Article  PubMed  PubMed Central  CAS  Google Scholar 

Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179(2):292–311

Article  PubMed  CAS  Google Scholar 

da Fonseca AC et al (2014) The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 8:362

Article  PubMed  PubMed Central  Google Scholar 

Liu Q et al (2019) Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca(2+)-dependent PKC/p38MAPK/NF-kappaB pathway. J Neuroinflammation 16(1):10

Article  PubMed  PubMed Central  Google Scholar 

Guo X et al (2021) PAID study design on the role of PKC activation in immune/inflammation-related depression: a randomised placebo-controlled trial protocol. Gen Psychiatr 34(2):e100440

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guo X et al (2020) Common cellular and molecular mechanisms and interactions between microglial activation and aberrant neuroplasticity in depression. Neuropharmacology 181:108336

Article  PubMed  CAS  Google Scholar 

Wu H et al (2021) Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation 18(2)

Wu W et al (2020) Microglial depletion aggravates the severity of acute and chronic seizures in mice. Brain Behav Immun 89:245–255

Article  PubMed  PubMed Central  CAS  Google Scholar 

Haruwaka K et al (2019) Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 10(1):5816

Article  PubMed  PubMed Central  CAS  Google Scholar 

Benson MJ, Manzanero S, Borges K (2015) Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models. Epilepsia 56(6):895–905

Article  PubMed  CAS  Google Scholar 

Enache D, Pariante CM, Mondelli V (2019) Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun 81:24–40

Article  PubMed  Google Scholar 

Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22–34

Article  PubMed  PubMed Central  CAS  Google Scholar 

Torres-Platas SG et al (2014) Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 42:50–59

Article  PubMed  CAS  Google Scholar 

Zhang L, Zhang J, You Z (2018) Switching of the microglial activation phenotype is a possible treatment for depression disorder. Front Cell Neurosci 12:306

Article  PubMed  PubMed Central  CAS  Google Scholar 

Duan CM et al (2020) SRT2104 attenuates chronic unpredictable mild stress-induced depressive-like behaviors and imbalance between microglial M1 and M2 phenotypes in the mice. Behav Brain Res 378:112296

Article  PubMed  CAS  Google Scholar 

Altmann A et al (2022) A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies. Neuropathol Appl Neurobiol 48(1):e12758

Article  PubMed  CAS  Google Scholar 

Hawrylycz MJ et al (2012) An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489(7416):391–399

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guelfi S et al (2019) Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy. Brain 142(6):1616–1630

Article  PubMed  Google Scholar 

Morin-Brureau M et al (2018) Microglial phenotypes in the human epileptic temporal lobe. Brain 141(12):3343–3360

Article  PubMed